| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
90,000,000 |
| Market
Cap: |
1.70(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$18.88 - $18.88 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Dow Stephen M |
Director |
– • – |
2015-08-11 |
4 |
S |
$40.40 |
$4,660,763 |
I/I |
(115,358) |
2,183,205 |
|
- |
|
| Sturiale Nicholas G |
Affiliate |
– – – |
2015-08-11 |
4 |
S |
$40.40 |
$4,660,763 |
I/I |
(115,358) |
1,909,125 |
|
- |
|
| Sevin Rosen Ix Affiliates Fund L.p. |
Affiliate |
– – – |
2015-08-11 |
4 |
S |
$40.40 |
$4,660,763 |
I/I |
(115,358) |
1,909,079 |
|
- |
|
| Smith Jeffrey T L |
Sr. VP Translational Medicine |
• – – |
2015-08-03 |
4 |
AS |
$45.64 |
$178,003 |
D/D |
(3,900) |
0 |
|
- |
|
| Smith Jeffrey T L |
Sr. VP Translational Medicine |
• – – |
2015-08-03 |
4 |
OE |
$0.39 |
$1,502 |
D/D |
3,900 |
3,900 |
|
- |
|
| Latham John A |
Chief Scientific Officer |
• – – |
2015-08-03 |
4 |
AS |
$45.62 |
$207,322 |
D/D |
(4,545) |
209,447 |
|
- |
|
| Latham John A |
Chief Scientific Officer |
• – – |
2015-08-03 |
4 |
OE |
$0.39 |
$1,750 |
D/D |
4,545 |
213,992 |
|
- |
|
| Smith Jeffrey T L |
Sr. VP Translational Medicine |
• – – |
2015-07-01 |
4 |
AS |
$51.18 |
$199,616 |
D/D |
(3,900) |
0 |
|
- |
|
| Smith Jeffrey T L |
Sr. VP Translational Medicine |
• – – |
2015-07-01 |
4 |
OE |
$0.39 |
$1,502 |
D/D |
3,900 |
3,900 |
|
- |
|
| Litton Mark James |
Chief Business Officer |
• – – |
2015-07-01 |
4 |
AS |
$51.10 |
$383,219 |
D/D |
(7,500) |
67,655 |
|
- |
|
| Latham John A |
Chief Scientific Officer |
• – – |
2015-07-01 |
4 |
AS |
$51.13 |
$232,381 |
D/D |
(4,545) |
209,447 |
|
- |
|
| Latham John A |
Chief Scientific Officer |
• – – |
2015-07-01 |
4 |
OE |
$0.39 |
$1,750 |
D/D |
4,545 |
213,992 |
|
- |
|
| Benedict Larry |
Sr. VP Finance |
• – – |
2015-06-12 |
4 |
S |
$47.46 |
$1,208,090 |
D/D |
(25,454) |
1,266 |
|
- |
|
| Benedict Larry |
Sr. VP Finance |
• – – |
2015-06-12 |
4 |
OE |
$1.65 |
$41,999 |
D/D |
25,454 |
26,720 |
|
- |
|
| Litton Mark James |
Chief Business Officer |
• – – |
2015-06-04 |
4 |
S |
$44.27 |
$1,106,853 |
D/D |
(25,000) |
75,155 |
|
- |
|
| Litton Mark James |
Chief Business Officer |
• – – |
2015-06-04 |
4 |
OE |
$0.39 |
$9,625 |
D/D |
25,000 |
100,155 |
|
- |
|
| Latham John A |
Chief Scientific Officer |
• – – |
2015-06-04 |
4 |
S |
$44.18 |
$1,104,463 |
D/D |
(25,000) |
209,447 |
|
- |
|
| Latham John A |
Chief Scientific Officer |
• – – |
2015-06-04 |
4 |
OE |
$0.39 |
$9,625 |
D/D |
25,000 |
234,447 |
|
- |
|
| Dow Stephen M |
Director |
– • • |
2015-06-04 |
4 |
A |
$0.00 |
$0 |
I/I |
8,962 |
2,298,563 |
|
- |
|
| Sturiale Nicholas G |
10% Owner |
– – • |
2015-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
25,276 |
2,340 |
|
- |
|
| Sevin Rosen Ix Affiliates Fund L.p. |
10% Owner |
– – • |
2015-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
46 |
46 |
|
- |
|
| Sevin Rosen Ix Affiliates Fund L.p. |
10% Owner |
– – • |
2015-06-04 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,024,483) |
2,024,483 |
|
- |
|
| Smith Jeffrey T L |
Sr. VP Translational Medicine |
• – – |
2015-06-01 |
4 |
AS |
$41.53 |
$161,969 |
D/D |
(3,900) |
0 |
|
- |
|
| Smith Jeffrey T L |
Sr. VP Translational Medicine |
• – – |
2015-06-01 |
4 |
OE |
$0.39 |
$1,502 |
D/D |
3,900 |
3,900 |
|
- |
|
| Latham John A |
Chief Scientific Officer |
• – – |
2015-06-01 |
4 |
AS |
$41.53 |
$188,757 |
D/D |
(4,545) |
209,447 |
|
- |
|
296 Records found
|
|
Page 9 of 12 |
|
|
